Safety and efficacy results from the expansion phase of the first-in-human study evaluating TGFß inhibitor SAR439459 alone and combined with cemiplimab in adults with advanced solid tumors

Robbrecht, Debbie ; Doger, Bernard ; Grob, Jean-Jacques ; Bechter, Oliver Edgar ; De Miguel, Maria J ; Vieito, Maria ; Schadendorf, Dirk ; Curigliano, Giuseppe ; Borbath, Ivan ; Butler, Marcus O ; Rodriguez-Vida, Alejo ; Miller, Wilson H ; Lin, Tun Tun ; Masson, Nina ; Pouzin, Clemence ; Wang, Rui ; Demers, Brigitte ; Amrate, Amele ; Abbadessa, Giovanni ; Simonelli, Matteo

JOURNAL OF CLINICAL ONCOLOGY, 2022, Vol.40 (16)

LIPPINCOTT WILLIAMS & WILKINS

Texto completo disponível